A sign for the Food and Drug Administration is displayed outside their offices in Silver Spring, Md., on Dec. 10, 2020. (AP Photo/Manuel Balce Ceneta, File)
U.S. health officials are alerting consumers about two more recalls of eyedrops due to contamination risks that could lead to vision problems and serious injury.
The announcements follow a recall last month of eyedrops made in India that were linked to an outbreak of drug-resistant infections. One person died and at least five others had permanent vision loss.
There's no indication the latest recalls are related to those products.
The Food and Drug Administration posted separate recall notices for certain eyedrops distributed by Pharmedica and Apotex after the companies said they are voluntarily pulling several lots of their products from the market. Both companies said the recalls were conducted in consultation with the FDA.
Pharmedica on Friday said it is recalling two lots of Purely Soothing 15% MSM Drops due to problems “that could result in blindness." The over-the-counter drops are designed to treat eye irritation. The Phoenix-based company said consumers should immediately stop using the drops and return them to the place they were purchased.
The recall affects nearly 2,900 bottles, according to the company. The drops were manufactured in Arizona.
Last week, the FDA posted a separate recall announcement from Apotex recalling six lots of prescription eyedrops used to treat a form of glaucoma. The company said it launched the recall after finding cracks in a handful of bottle caps.
The drops are distributed as Brimonidine Tartrate Ophthalmic Solution. 0.15% and were sold between last April through February.
Apotex said in an email that the eyedrops were manufactured in Canada. The company hasn't received any reports of injuries related to the drops.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
The recent California oil spill has wreaked havoc on the shores of Huntington Beach as wildlife habitats and potentially some people have been exposed to the 140,000+ gallons of oil in the ocean. Cheddar News was joined by Dr. Deborah Bronsan, President of Deborah Bronson & Associates to learn more about the environmental dangers and how the area can recover from this tragedy.
Blue Bear Capital, a venture and growth equity firm focusing on AI-powered solutions for the world’s energy, infrastructure, and climate challenges, recently announced it has raised $150 million dollars in new funding. Ernst Sack, Partner at Blue Bear Capital, joins Cheddar Climate the vision his company has when it comes to combating climate change.
Several major carriers have followed in the steps of United Airlines and will now require its staff to be vaccinated against COVID-19. Those airlines include American, Jet Blue, and Alaskan.
Jeff Bezos' space travel company Blue Origin is under fire after a group of 20 current and former employees signed a letter to the FAA claiming safety violations that were detailed along with accusations of sexual harassment.
Futures rebounded this morning in reaction to positive news from Merck that its covid-19 treatment pill is 50 percent effective at preventing hospitalizations and death. It comes after a rocky month on Wall Street, which saw all the major averages post their worst months in over a year. Chris Vecchio, Senior Analyst, at DailyFX joined Wake Up with Cheddar for more.
The FAA has completed its investigation of Virgin Galactic’s Unity 22 test flight on July 12 after the aircraft flew out of protected airspace on its descent back to Earth. Virgin Galactic has been given the green light to resume flights but must request a larger share of protected airspace for future missions.
